Cipla

CIPLA · NSE · INR

₹ 1.344,00Variação em relação ao fechamento anterior: −0,15%Variação absoluta: −₹ 2,00

Fechamento · 1 de outubro de 2026

Perfil da empresa

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Descrição disponível em inglês.

Dados da empresa

Setor
Saúde
Indústria
Drug Manufacturers - Specialty & Generic
País
Índia
Sede
Cipla House, 400013, Mumbai
Funcionários
31.369
Listagem
CIPLA · NSE
Moeda
INR
ISIN
INE059A01026